Jim Stanker | CFO |
David Young | President & CEO |
Naz Rahman | Maxim Group |
Greetings and welcome to the Processa Pharmaceuticals Year-End 2022 Earnings Call and Corporate Update. [Operator Instructions] As a reminder, this call is being recorded.
It is now my pleasure to introduce Jim Stanker, Chief Financial Officer. Thank you, sir.
You may begin.